Surgery Partners, Inc. (NASDAQ:SGRY) Shares Bought by Pathstone Holdings LLC

Pathstone Holdings LLC raised its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 30.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 57,347 shares of the company’s stock after acquiring an additional 13,534 shares during the period. Pathstone Holdings LLC’s holdings in Surgery Partners were worth $1,849,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Royce & Associates LP boosted its stake in Surgery Partners by 12.2% in the third quarter. Royce & Associates LP now owns 510,261 shares of the company’s stock valued at $16,451,000 after acquiring an additional 55,545 shares during the period. Lombard Odier Asset Management Europe Ltd bought a new stake in shares of Surgery Partners during the second quarter valued at approximately $4,163,000. Rhumbline Advisers raised its holdings in shares of Surgery Partners by 19.6% during the second quarter. Rhumbline Advisers now owns 127,952 shares of the company’s stock valued at $3,044,000 after buying an additional 20,963 shares during the last quarter. Point72 Asset Management L.P. bought a new stake in shares of Surgery Partners during the second quarter valued at approximately $29,288,000. Finally, Victory Capital Management Inc. raised its holdings in shares of Surgery Partners by 140.4% during the third quarter. Victory Capital Management Inc. now owns 1,330,399 shares of the company’s stock valued at $42,892,000 after buying an additional 777,038 shares during the last quarter.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on SGRY. Royal Bank of Canada cut their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a report on Wednesday, November 20th. Benchmark reaffirmed a “buy” rating and set a $50.00 price target on shares of Surgery Partners in a report on Monday, August 26th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $43.00 price target on shares of Surgery Partners in a report on Friday, October 4th. StockNews.com cut Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. Finally, Macquarie reaffirmed an “outperform” rating and set a $34.00 price target on shares of Surgery Partners in a report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Surgery Partners presently has a consensus rating of “Moderate Buy” and an average price target of $38.71.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $23.41 on Thursday. Surgery Partners, Inc. has a 12 month low of $21.36 and a 12 month high of $36.92. The stock has a market cap of $2.98 billion, a price-to-earnings ratio of -47.69, a PEG ratio of 19.47 and a beta of 2.76. The stock’s 50 day moving average price is $29.52 and its 200 day moving average price is $28.31. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $770.40 million for the quarter, compared to the consensus estimate of $768.99 million. During the same period in the previous year, the firm earned $0.15 EPS. Surgery Partners’s revenue for the quarter was up 14.3% on a year-over-year basis. Equities research analysts anticipate that Surgery Partners, Inc. will post 0.73 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.